Stay updated with breaking news from Biolase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BIOLASE, Inc. (NASDAQ:BIOL – Get Free Report) was the target of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 288,900 shares, a growth of 17.6% from the February 29th total of 245,600 shares. Based on an average daily volume of 4,800,000 shares, the […] ....
BIOLASE, Inc. (NASDAQ:BIOL – Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 288,900 shares, an increase of 17.6% from the February 29th total of 245,600 shares. Based on an average daily volume of 4,800,000 shares, the […] ....
BIOLASE, Inc. (NASDAQ:BIOL – Get Free Report) saw a large drop in short interest in the month of February. As of February 29th, there was short interest totalling 245,600 shares, a drop of 63.8% from the February 14th total of 678,600 shares. Based on an average daily volume of 2,010,000 shares, the days-to-cover ratio is […] ....
StockNews.com upgraded shares of BIOLASE (NASDAQ:BIOL – Free Report) from a sell rating to a hold rating in a research report report published on Tuesday morning. BIOLASE Trading Up 18.3 % BIOLASE stock opened at $0.50 on Tuesday. The stock has a 50-day moving average of $1.01 and a two-hundred day moving average of $6.94. […] ....
StockNews.com lowered shares of BIOLASE (NASDAQ:BIOL – Free Report) from a hold rating to a sell rating in a research report report published on Thursday. BIOLASE Price Performance Shares of NASDAQ:BIOL traded up $0.04 during midday trading on Thursday, reaching $0.89. 45,625 shares of the company were exchanged, compared to its average volume of 74,141. […] ....